Review Article
Successfully Improving Ocular Drug Delivery Using the Cationic Nanoemulsion, Novasorb
Table 10
Key drivers of cationic emulsion technology Novasorb.
| (i) Solubilization of large doses of lipophilic drugs and/or large molecules | | (ii) Better penetration through membranes resulting in enhanced bioavailability | | (iii) Potential for drug controlled release | | (iv) Stable and can be sterilized | | (v) Addition of effective novel routes of administration to existing marketed drugs | | (vi) Expanding markets and indications | | (vii) Extending product life cycles | | (viii) Generating new opportunities | | (ix) Inexpensive to manufacture | |
|
|